Announcements

MiniMed Group, Inc. filed a current report on Form 8-K on September 1, 2026, announcing the release of its financial results for the first quarter of fiscal year 2027, ended July 31, 2026.

NovoCure Limited filed a Form 8-K on September 1, 2026, disclosing that in mid-August 2026 the company detected unauthorized access to some of its information systems, exposing limited patient and employee data.

Upstream Bio, Inc. filed a Form 8-K with the SEC on September 1, 2026, disclosing its pivotal Phase 3 development plans for verekitug in severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP).

Yum China Holdings, Inc. filed a Form 8-K on September 1, 2026, disclosing under Regulation FD that it issued an interim report covering the six months ended June 30, 2026, in compliance with the listing rules of The Stock Exchange of Hong Kong Limited.

Humana Inc. filed an 8-K with the Securities and Exchange Commission on September 1, 2026, disclosing that senior management intends to reaffirm full-year 2026 earnings guidance during investor and analyst meetings scheduled through September 30, 2026.

Yext, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on September 1, 2026, announcing its financial results for the second fiscal quarter ended July 31, 2026, along with a stockholder letter and a product update press release.

Keurig Dr Pepper Inc. filed a Form 8-K on September 1, 2026, disclosing that its wholly-owned subsidiary Mott's LLP entered into definitive agreements on August 28, 2026, to exit the company's indirect equity interests in Chobani and sell certain related assets for total aggregate …